$ARNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARENA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARENA PHARMACEUTICALS INC. Get notifications about new insider transactions in ARENA PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Sell | S | 44.00 | 3,000 | 132,000 | 0 | 3 K to 0 (-100.00 %) |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Sell | S | 44.00 | 3,000 | 132,000 | 0 | 3 K to 0 (-100.00 %) |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Buy | M | 15.10 | 3,000 | 45,300 | 3,000 | 0 to 3 K |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Buy | M | 15.10 | 3,000 | 45,300 | 3,000 | 0 to 3 K |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Sell | S | 42.32 | 400 | 16,927 | 0 | 400 to 0 (-100.00 %) |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Sell | S | 42.32 | 400 | 16,927 | 0 | 400 to 0 (-100.00 %) |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Sell | S | 41.68 | 15,600 | 650,139 | 400 | 16 K to 400 (-97.50 %) |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Sell | S | 41.68 | 15,600 | 650,139 | 400 | 16 K to 400 (-97.50 %) |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Buy | M | 15.10 | 16,000 | 241,600 | 16,000 | 0 to 16 K |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Buy | M | 15.10 | 16,000 | 241,600 | 16,000 | 0 to 16 K |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 0.00 | 12,600 | 0 | 12,600 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 0.00 | 12,600 | 0 | 12,600 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 40.94 | 75,000 | 3,070,500 | 75,000 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 40.94 | 75,000 | 3,070,500 | 75,000 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 40.94 | 75,000 | 3,070,500 | 75,000 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 40.94 | 75,000 | 3,070,500 | 75,000 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Option Exercise | A | 0.00 | 12,600 | 0 | 12,600 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Option Exercise | A | 0.00 | 12,600 | 0 | 12,600 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Option Exercise | A | 40.94 | 75,000 | 3,070,500 | 75,000 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Option Exercise | A | 40.94 | 75,000 | 3,070,500 | 75,000 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | A | 0.00 | 23,400 | 0 | 23,400 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | A | 0.00 | 23,400 | 0 | 23,400 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | A | 40.94 | 285,000 | 11,667,900 | 285,000 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | A | 40.94 | 285,000 | 11,667,900 | 285,000 | |
Dec 17 2018 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Option Exercise | A | 41.09 | 2,500 | 102,725 | 2,500 | |
Dec 17 2018 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Option Exercise | A | 41.09 | 2,500 | 102,725 | 2,500 | |
Dec 17 2018 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Grant | A | 0.00 | 1,825 | 0 | 1,825 | 0 to 1.8 K |
Dec 17 2018 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Grant | A | 0.00 | 1,825 | 0 | 1,825 | 0 to 1.8 K |
Aug 17 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 18.10 | 29,005 | 524,991 | 5,525 | |
Aug 17 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 36.69 | 3,943 | 144,676 | 19,690 | 23.6 K to 19.7 K (-16.68 %) |
Aug 17 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 35.90 | 25,062 | 899,829 | 23,633 | 48.7 K to 23.6 K (-51.47 %) |
Aug 17 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 18.10 | 29,005 | 524,991 | 48,695 | 19.7 K to 48.7 K (+147.31 %) |
Jul 10 2018 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Option Exercise | A | 44.79 | 4,583 | 205,273 | 4,583 | |
Jul 10 2018 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Option Exercise | A | 44.79 | 2,500 | 111,975 | 2,500 | |
Jul 10 2018 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 3,070 | 0 | 4,744 | 1.7 K to 4.7 K (+183.39 %) |
Jul 10 2018 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 1,674 | 0 | 1,674 | 0 to 1.7 K |
Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | A | 49.17 | 5,000 | 245,850 | 5,000 | |
Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Grant | A | 0.00 | 3,050 | 0 | 11,576 | 8.5 K to 11.6 K (+35.77 %) |
Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | A | 49.17 | 5,000 | 245,850 | 5,000 | |
Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Grant | A | 0.00 | 3,050 | 0 | 11,476 | 8.4 K to 11.5 K (+36.20 %) |
Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 49.17 | 5,000 | 245,850 | 5,000 | |
Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Grant | A | 0.00 | 3,050 | 0 | 3,050 | 0 to 3.1 K |
Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 49.17 | 5,000 | 245,850 | 5,000 | |
Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Grant | A | 0.00 | 3,050 | 0 | 3,050 | 0 to 3.1 K |
Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | FETZER OLIVER | Director | Option Exercise | A | 49.17 | 5,000 | 245,850 | 5,000 | |
Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | FETZER OLIVER | Director | Grant | A | 0.00 | 3,050 | 0 | 3,050 | 0 to 3.1 K |
Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Option Exercise | A | 49.17 | 5,000 | 245,850 | 5,000 | |
Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Grant | A | 0.00 | 3,050 | 0 | 3,050 | 0 to 3.1 K |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 18.10 | 15,000 | 271,500 | 34,530 | |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 17.90 | 15,001 | 268,518 | 14,999 | |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 35.81 | 1,400 | 50,135 | 19,690 | 21.1 K to 19.7 K (-6.64 %) |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 35.00 | 7,700 | 269,467 | 21,090 | 28.8 K to 21.1 K (-26.75 %) |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 34.33 | 20,901 | 717,456 | 28,790 | 49.7 K to 28.8 K (-42.06 %) |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 18.10 | 15,000 | 271,500 | 49,691 | 34.7 K to 49.7 K (+43.24 %) |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 17.90 | 15,001 | 268,518 | 34,691 | 19.7 K to 34.7 K (+76.19 %) |
Mar 06 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Payment of Exercise | F | 42.80 | 3,874 | 165,807 | 19,690 | 23.6 K to 19.7 K (-16.44 %) |
Mar 06 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Grant | A | 0.00 | 11,205 | 0 | 23,564 | 12.4 K to 23.6 K (+90.66 %) |
Jan 22 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 35.60 | 130,000 | 4,628,000 | 130,000 | |
Jan 22 2018 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 35.60 | 130,000 | 4,628,000 | 130,000 | |
Jan 22 2018 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Option Exercise | A | 35.60 | 130,000 | 4,628,000 | 130,000 | |
Jan 22 2018 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Option Exercise | A | 35.60 | 130,000 | 4,628,000 | 130,000 | |
Jan 22 2018 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | A | 35.60 | 310,000 | 11,036,000 | 310,000 | |
Dec 19 2017 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Payment of Exercise | F | 30.23 | 281 | 8,495 | 12,359 | 12.6 K to 12.4 K (-2.22 %) |
Dec 19 2017 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Payment of Exercise | F | 30.23 | 234 | 7,074 | 12,640 | 12.9 K to 12.6 K (-1.82 %) |
Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | A | 1.36 | 150,000 | 204,000 | 150,000 | |
Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Option Exercise | A | 1.36 | 150,000 | 204,000 | 150,000 | |
Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Option Exercise | A | 1.36 | 150,000 | 204,000 | 150,000 | |
Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | A | 1.36 | 150,000 | 204,000 | 150,000 | |
Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 1.36 | 150,000 | 204,000 | 150,000 | |
Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | FETZER OLIVER | Director | Option Exercise | A | 1.36 | 150,000 | 204,000 | 150,000 | |
Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Option Exercise | A | 1.36 | 150,000 | 204,000 | 150,000 | |
Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Option Exercise | A | 1.36 | 150,000 | 204,000 | 150,000 | |
Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 1.36 | 150,000 | 204,000 | 150,000 | |
Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 1.36 | 75,000 | 102,000 | 75,000 | |
May 15 2017 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | P | 1.19 | 25,000 | 29,750 | 76,875 | 51.9 K to 76.9 K (+48.19 %) |
Apr 27 2017 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | P | 1.41 | 50,000 | 70,500 | 51,875 | 1.9 K to 51.9 K (+2,666.67 %) |
Apr 27 2017 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | J | 1.24 | 625 | 775 | 1,875 | 1.3 K to 1.9 K (+50.00 %) |
Mar 20 2017 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Option Exercise | A | 1.50 | 1,293,500 | 1,940,250 | 1,293,500 | |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | A | 1.46 | 2,150,000 | 3,139,000 | 2,150,000 | |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | J | 1.21 | 625 | 756 | 1,250 | 625 to 1.3 K (+100.00 %) |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | J | 1.41 | 625 | 881 | 625 | 0 to 625 |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Option Exercise | A | 1.46 | 1,044,750 | 1,525,335 | 1,044,750 | |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Buy | J | 1.21 | 625 | 756 | 1,250 | 625 to 1.3 K (+100.00 %) |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Buy | J | 1.41 | 625 | 881 | 625 | 0 to 625 |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 1.46 | 1,044,750 | 1,525,335 | 1,044,750 | |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 1.46 | 995,000 | 1,452,700 | 995,000 | |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 1.46 | 41,666 | 60,832 | 41,666 | |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 1.46 | 75,000 | 109,500 | 75,000 | |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | FETZER OLIVER | Director | Option Exercise | A | 1.46 | 41,666 | 60,832 | 41,666 | |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | FETZER OLIVER | Director | Option Exercise | A | 1.46 | 75,000 | 109,500 | 75,000 | |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Option Exercise | A | 1.46 | 41,666 | 60,832 | 41,666 | |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Option Exercise | A | 1.46 | 75,000 | 109,500 | 75,000 | |
Dec 16 2016 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 1.50 | 342,000 | 513,000 | 342,000 | |
Aug 15 2016 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 1.71 | 800,000 | 1,368,000 | 800,000 | |
Aug 15 2016 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 1.71 | 800,000 | 1,368,000 | 800,000 | |
Jun 15 2016 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Option Exercise | A | 1.94 | 800,000 | 1,552,000 | 800,000 | |
Jun 15 2016 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Option Exercise | A | 2.00 | 125,000 | 250,000 | 125,000 | |
Jun 15 2016 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Sell | S | 1.99 | 18,728 | 37,299 | 85,529 | 104.3 K to 85.5 K (-17.96 %) |
Jun 15 2016 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | A | 2.00 | 125,000 | 250,000 | 125,000 | |
Jun 15 2016 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Option Exercise | A | 2.00 | 125,000 | 250,000 | 125,000 | |
Jun 15 2016 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | A | 2.00 | 125,000 | 250,000 | 125,000 | |
Jun 15 2016 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | A | 2.00 | 125,000 | 250,000 | 125,000 | |
Jun 15 2016 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Option Exercise | A | 2.00 | 125,000 | 250,000 | 125,000 | |
Jun 15 2016 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Option Exercise | A | 2.00 | 125,000 | 250,000 | 125,000 | |
May 11 2016 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | A | 1.55 | 3,800,000 | 5,890,000 | 3,800,000 | |
Mar 04 2016 | ARNA | ARENA PHARMACEUTIC ... | Mezzino Maurice James | SVP, Corporate Deve ... | Option Exercise | A | 1.55 | 175,000 | 271,250 | 175,000 | |
Mar 04 2016 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Option Exercise | A | 1.55 | 207,500 | 321,625 | 207,500 | |
Mar 04 2016 | ARNA | ARENA PHARMACEUTIC ... | Bielasz Jennifer Kathleen | VP, Finance and Acc ... | Option Exercise | A | 1.55 | 252,000 | 390,600 | 252,000 | |
Mar 04 2016 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Option Exercise | A | 1.55 | 207,500 | 321,625 | 207,500 | |
Mar 04 2016 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 1.55 | 525,000 | 813,750 | 525,000 | |
Mar 04 2016 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Option Exercise | A | 1.55 | 525,000 | 813,750 | 525,000 | |
Dec 18 2015 | ARNA | ARENA PHARMACEUTIC ... | Mezzino Maurice James | SVP, Corporate Deve ... | Option Exercise | A | 1.89 | 175,000 | 330,750 | 175,000 | |
Dec 17 2015 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Option Exercise | A | 1.79 | 175,000 | 313,250 | 175,000 | |
Dec 17 2015 | ARNA | ARENA PHARMACEUTIC ... | Bielasz Jennifer Kathleen | VP, Accounting & Co ... | Option Exercise | A | 1.79 | 90,000 | 161,100 | 90,000 | |
Dec 17 2015 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Option Exercise | A | 1.79 | 175,000 | 313,250 | 175,000 | |
Dec 17 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 1.79 | 300,000 | 537,000 | 300,000 | |
Dec 17 2015 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Option Exercise | A | 1.79 | 300,000 | 537,000 | 300,000 | |
Jun 16 2015 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Grant | A | 0.00 | 40,145 | 0 | 104,257 | 64.1 K to 104.3 K (+62.62 %) |
Jun 16 2015 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Grant | A | 0.00 | 40,145 | 0 | 84,257 | 44.1 K to 84.3 K (+91.01 %) |
Jun 16 2015 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Grant | A | 0.00 | 40,145 | 0 | 89,157 | 49 K to 89.2 K (+81.91 %) |
Jun 16 2015 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Grant | A | 0.00 | 40,145 | 0 | 134,257 | 94.1 K to 134.3 K (+42.66 %) |
Jun 16 2015 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Grant | A | 0.00 | 40,145 | 0 | 85,257 | 45.1 K to 85.3 K (+88.99 %) |
Jun 16 2015 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Grant | A | 0.00 | 40,145 | 0 | 94,257 | 54.1 K to 94.3 K (+74.19 %) |
Jun 16 2015 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Grant | A | 0.00 | 40,145 | 0 | 148,405 | 108.3 K to 148.4 K (+37.08 %) |
Apr 01 2015 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | M | 1.27 | 36,000 | 45,720 | 0 | |
Apr 01 2015 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | M | 1.49 | 40,268 | 59,999 | 12,000 | |
Apr 01 2015 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Sell | S | 4.49 | 76,268 | 342,253 | 45,112 | 121.4 K to 45.1 K (-62.83 %) |
Apr 01 2015 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Buy | M | 1.27 | 36,000 | 45,720 | 121,380 | 85.4 K to 121.4 K (+42.16 %) |
Apr 01 2015 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Buy | M | 1.49 | 40,268 | 59,999 | 85,380 | 45.1 K to 85.4 K (+89.26 %) |
Mar 18 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 1.81 | 4,698 | 8,503 | 495,302 | |
Mar 18 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 1.49 | 65,302 | 97,300 | 79,698 | |
Mar 18 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 5.00 | 70,000 | 350,000 | 128,039 | 198 K to 128 K (-35.35 %) |
Mar 18 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 1.81 | 4,698 | 8,503 | 198,039 | 193.3 K to 198 K (+2.43 %) |
Mar 18 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 1.49 | 65,302 | 97,300 | 193,341 | 128 K to 193.3 K (+51.00 %) |
Mar 04 2015 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | President and CEO | Option Exercise | M | 1.49 | 125,000 | 186,250 | 75,000 | |
Mar 04 2015 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | President and CEO | Buy | M | 1.49 | 125,000 | 186,250 | 622,189 | 497.2 K to 622.2 K (+25.14 %) |
Jan 08 2015 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Option Exercise | M | 1.49 | 50,000 | 74,500 | 150,000 | |
Jan 08 2015 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Sell | S | 5.49 | 50,000 | 274,500 | 50,000 | 100 K to 50 K (-50.00 %) |
Jan 08 2015 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Buy | M | 1.49 | 50,000 | 74,500 | 100,000 | 50 K to 100 K (+100.00 %) |
Jan 08 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 6.16 | 45,000 | 277,200 | 0 | |
Jan 08 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 6.26 | 45,000 | 281,700 | 128,039 | 173 K to 128 K (-26.01 %) |
Jan 08 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 6.16 | 45,000 | 277,200 | 173,039 | 128 K to 173 K (+35.15 %) |
Dec 17 2014 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Option Exercise | A | 3.72 | 45,000 | 167,400 | 45,000 | |
Dec 17 2014 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Grant | A | 0.00 | 15,000 | 0 | 50,000 | 35 K to 50 K (+42.86 %) |
Dec 17 2014 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Option Exercise | A | 3.72 | 45,000 | 167,400 | 45,000 | |
Dec 17 2014 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Grant | A | 0.00 | 15,000 | 0 | 50,000 | 35 K to 50 K (+42.86 %) |
Dec 17 2014 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 3.72 | 75,000 | 279,000 | 75,000 | |
Dec 17 2014 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Grant | A | 0.00 | 25,000 | 0 | 127,687 | 102.7 K to 127.7 K (+24.35 %) |